The Market has never been stronger, both the Dow and Nasdaq set new records, however, that didn’t deter the determined short sellers who pounced on America’s favorite retailers like hungry Sharks, they targeted Macy’s, M and Kohl’s, KSS  

Macy’s, the iconic retailer, provided the most sumptuous Thanksgiving meal you could imagine, and the payout from Macy’s alone was a stunning $597 million dollar!

And Kohl’s, a store famous for deeply discounted designer clothing & shoes, offered a huge buffet to these hungry Orcas. Short Sellers made a whopping $556 million on Kohl’s.

Carl Icahn, who prefers to gobble up the whole thing like a Humpback Whale, is going after the Mall owners, instead of shorting one store at a time, according to The Wall Street Journal. Icahn is hoping to make $400 million, will he succeed? Only time will tell, Mall owners, however, are a savvy bunch and they would love to make an example out of him and put a life-sized Icahn on display.

Editor Daily Stock Deals

Gain Insight, Trade with Confidence, Click here to Join Fellow Investors

Source: WSJ, OxBridge Research, Daily Stock Deals

In October 2019, Biogen, BIIB, stunned the medical community by announcing that it will seek FDA approval for a drug that it had discarded more than six month ago. The company and its partner, Eisai, at that time said that the drug failed to significantly improve cognitive functions in Alzheimer’s patients.

Why change of heart?

The company now claims that they ‘overlooked’ some critical data and a more closer analysis of the data revealed that a group of trial participants who were given a larger doses of the drug had a significant improvement in cognitive functions, the company said that it has submitted the newly discovered data to the FDA and is seeking approval to market the drug. 

The announcement unleashed a stock buying frenzy that added a whopping $12 billion to the company’s market cap, remember, the drug has not been approved yet! 

More than 6 million Americans are suffering from Alzheimer’s and there is no drug to stop it, so the company is betting that the FDA may approve the drug despite the treatment only marginally improves the quality of life. Alzheimer’s is a brutal disease that slowly takes away the ability to live and look after oneself, most patients suffer severe dementia and ultimate death.

Editor Daily Stock Deals

Gain Insight, Trade with Confidence, Join Fellow Investors, click now

 Source: NIH, CDC, OxBridge Research, Daily Stock Deals

TOP 10 E-Cigarettes and Vaping Facts you should know!

Top 10 Facts

Update from the CDC November 8, 2019, at 1:00 PM EST

Recent CDC laboratory testing of bronchoalveolar lavage (BAL) fluid samples (or samples of fluid collected from the lungs) from 29 patients with EVALI submitted to CDC from 10 states found vitamin E acetate in all of the BAL fluid samples.  Vitamin E acetate is used as an additive in the production of e-cigarette, or vaping, products. This is the first time that we have detected a potential chemical of concern in biologic samples from patients with these lung injuries.

CDC continues to recommend that people should not use e-cigarette, or vaping, products that contain THC, particularly from informal sources like friends, or family, or in-person or online dealers. We will continue to provide updates as more data become available.

New Laboratory Findings:

• Analyses of bronchoalveolar lavage (BAL) fluid samples (or samples of fluid collected from the lungs) of patients with e-cigarette, or vaping, product use associated lung injury identified vitamin E acetate, an additive in some THC-containing products.
• Recent CDC laboratory test results of BAL samples from 29 patients submitted to CDC from 10 states identified vitamin E acetate in all BAL fluid samples. THC was identified in 82% of the samples and nicotine was identified in 62% of the samples.
  • CDC tested for a range of other chemicals that might be found in e-cigarette, or vaping, products, including plant oils, petroleum distillates like mineral oil, MCT oil, and terpenes (which are compounds found in or added to THC products). None of these potential chemicals of concern were detected in the BAL fluid samples tested.
• This is the first time that we have detected a potential chemical of concern in biologic samples from patients with these lung injuries. These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs.
• These findings complement the ongoing work of FDAexternal icon and some state public health laboratories to characterize e-liquid exposures and inform the ongoing multistate outbreak.

About the Outbreak:

• As of November 5, 2019, 2,051* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 1 U.S. territory.
  • Thirty-nine deaths have been confirmed in 24 states and the District of Columbia (as of November 5, 2019).
  • Latest outbreak information is updated every Thursday.
  • CDC continues to work closely with FDA, states, public health partners, and clinicians on this investigation.

About Patient Exposure:

• All EVALI patients have reported a history of using e-cigarette, or vaping, products.
  • THC is present in most of the samples tested by FDA to date, and most patients report a history of using THC-containing products.
  • The latest national and state findings suggest products containing THC, particularly from informal sources like friends, or family, or in-person or online dealers, are linked to most of the cases and play a major role in the outbreak.

Editor’s note:

Extremely Confidential and Highly Insightful Report by OxBridge Research, every Cannabis Company CEO must read ‘The Future of Cannabis in America’ and Canada Cannabis Inc. Contact now!

The report contains exclusive content on: JUUL's Rise & Fall, and how JUUL’s problems, CDC, FDA crackdown and impending Federal/State regulations may affect the future of Cannabis Industry and how you can deftly navigate, stay complaint and thrive, while your competition slowly withers away! 

Get Yours: Contact now!

TOP 10 E-Cigarettes and Vaping Facts you should know!

Top 10 Facts

Vaping crisis caught the regulators, Big Tobacco (Altria) and Investment Bankers (Fidelity) completely off guard. Billions of dollars vanished as the mysterious lung illness continue to claim lives.

JUUL, the fast growing Silicon Valley startup that made vaping cool and glamourous, hired high profile celebrities, organized parties at campuses. JUUL’s clever marketing campaign was so successful that it quickly became the dominant market leader with sales reaching $1.29 billion and that attracted the attention of big money managers like Fidelity Investments and Big Tobacco, Altria.

Altria surprised market insiders and investors when they announced a whopping $13 Billion dollar investment in JUUL, at the time it was considered a bold strategic move, unbeknownst to them, parents, college administrators and regulators were increasingly concerned about the rapid rise in vaping then doctors noticed something strange, young healthy people were coming to ER with a strange lung disease. CDC started monitoring and gathering data from around the country and determined that the mysterious lung diseases was caused by vaping.

Latest CDC Report released on October 29, 2019.

Thirty Seven deaths and 1,888 Injuries, cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 1 U.S. territory.

• Thirty seven deaths in 24 states and the District of Columbia: Alabama, California (3), Connecticut, Delaware, Florida, Georgia (3), Illinois (2), Indiana (3), Kansas (2), Massachusetts, Michigan, Minnesota (3), Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon (2), Pennsylvania, Tennessee (2), Texas, Utah, and Virginia

CDC/FDA still don’t know the exact cause of the illness, no single product has been identified and JUUL products are not linked to any deaths or illness. However, regulators decided to warn against vaping and considering a ban on flavored vaping products, JUUL voluntarily stopped selling flavored products at retail stores and introduced strict age verification system. The problem for JULL is that 80% of its revenues came from the flavored products and that’s why Altria has no choice but to cut the Value of JUUL by $14 billion and wrote off a whopping $4 billion dollar in a matter of few months.

Editor’s note:

Extremely Confidential and Highly Insightful Report by OxBridge Research, every Cannabis Company CEO must read ‘The Future of Cannabis in America’ and Canada Cannabis Inc. Contact now!

The report contains exclusive content on: JUUL's Rise & Fall, and how JUUL’s problems, CDC, FDA crackdown and impending Federal/State regulations may affect the future of Cannabis Industry and how you can deftly navigate, stay complaint and thrive, while your competition slowly withers away! 

Get Yours: Contact now!

TOP 10 E-Cigarettes and Vaping Facts you should know!

Top 10 Facts